Intracellular Th Stock Probability of Future Stock Price Finishing Under 78.68
| ITCI Stock | USD 85.69 0.24 0.28% |
Intracellular |
Intracellular Target Price Odds to finish below 78.68
The tendency of Intracellular Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 78.68 or more in 90 days |
| 85.69 | 90 days | 78.68 | about 54.85 |
Based on a normal probability distribution, the odds of Intracellular to drop to $ 78.68 or more in 90 days from now is about 54.85 (This Intracellular Th probability density function shows the probability of Intracellular Stock to fall within a particular range of prices over 90 days) . Probability of Intracellular Th price to stay between $ 78.68 and its current price of $85.69 at the end of the 90-day period is about 35.4 .
Given the investment horizon of 90 days Intracellular has a beta of 0.79. This usually indicates as returns on the market go up, Intracellular average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Intracellular Th will be expected to be much smaller as well. Additionally Intracellular Th has an alpha of 0.1308, implying that it can generate a 0.13 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Intracellular Price Density |
| Price |
Predictive Modules for Intracellular
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Intracellular Th. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Intracellular's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intracellular Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Intracellular is not an exception. The market had few large corrections towards the Intracellular's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Intracellular Th, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Intracellular within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.13 | |
β | Beta against Dow Jones | 0.79 | |
σ | Overall volatility | 5.94 | |
Ir | Information ratio | 0.05 |
Intracellular Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Intracellular for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Intracellular Th can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 464.37 M. Net Loss for the year was (139.67 M) with profit before overhead, payroll, taxes, and interest of 95.16 M. | |
| Intracellular Th currently holds about 628.74 M in cash with (124.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.64. | |
| Over 96.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Intra-cellular therapies president sells 3.69 million in stock |
Intracellular Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Intracellular Stock often depends not only on the future outlook of the current and potential Intracellular's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intracellular's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 95.9 M | |
| Cash And Short Term Investments | 497.9 M |
Intracellular Technical Analysis
Intracellular's future price can be derived by breaking down and analyzing its technical indicators over time. Intracellular Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Intracellular Th. In general, you should focus on analyzing Intracellular Stock price patterns and their correlations with different microeconomic environments and drivers.
Intracellular Predictive Forecast Models
Intracellular's time-series forecasting models is one of many Intracellular's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Intracellular's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Intracellular Th
Checking the ongoing alerts about Intracellular for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Intracellular Th help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| The company reported the previous year's revenue of 464.37 M. Net Loss for the year was (139.67 M) with profit before overhead, payroll, taxes, and interest of 95.16 M. | |
| Intracellular Th currently holds about 628.74 M in cash with (124.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.64. | |
| Over 96.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Intra-cellular therapies president sells 3.69 million in stock |
Check out Intracellular Backtesting, Intracellular Valuation, Intracellular Correlation, Intracellular Hype Analysis, Intracellular Volatility, Intracellular History as well as Intracellular Performance. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.87) | Revenue Per Share 6.096 | Quarterly Revenue Growth 0.39 | Return On Assets (0.07) | Return On Equity (0.1) |
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.